News from Antibody Solutions

Roche Acquires Adheron Therapeutics and Lead Asset, SDP051
Adheron Therapeutics has been acquired by Roche in a deal worth up to $580 million. The lead asset, SDP051, a humanized monoclonal antibody targeting Cadherin-11, has completed Phase 1 of clinical dev... ...more, comments
Abs to Difficult Membrane Proteins
"Antibody Development Strategies for Difficult Membrane Proteins" will be presented by Dr John Kenney at the Discovery On Target meeting in Boston, Sept. 24, 2015 at 12:50 PM, Westin Boston Waterfront... ...more, comments
AAPS-NBC 2015 Exhibit Hall Pass
We are exhibiting at the AAPS National Biotech Conference June 8th and 9th at the Marriott Marquis in San Francisco. See below for the registration link and Promo Code for a free one-day conference... ...more, comments
Antibody Solutions to Attend AAPS National Biotechnology Conference
Antibody Solutions will be attending the AAPS National Biotechnology Conference, June 8-10, 2015 at the San Francisco Marriott Marquis. ...more, comments
Dr. Kenney Speaker at Peptalk 2015
Dr. John Kenney was a speaker for the Membrane Proteins Track, Discovery and Development of Antibody Targets. Dr. Kenney's talk was entitled "Strategies to Obtain Antibodies to Difficult Membrane Tar... ...more, comments


News-Medical.Net Antibodies News Feed

Latest Antibodies News and Research

A team of scientists from the VIB lab of Han Remaut and the lab of Yves Dufrêne at UCL Louvain-La-Neuve collaborated on a study of functional amyloids -protein aggregates with the typical amyloid structure that do not lead to disease but rather serve a dedicated biological function.
Posted: June 21, 2017, 8:11 am
In people with high cholesterol levels, the fat that is built up in the artery walls narrows the arteries causing a condition called atherosclerosis. A study published on 19th June in the European Heart Journal has found the likelihood of a vaccine that can immunize humans having atherosclerosis, subsequent to successful outcomes in a mouse model study. At present, phase I clinical trial has begun in patients to see the possibility of translating the study findings to humans.
Posted: June 20, 2017, 3:04 pm
Scientists at The Scripps Research Institute have shown that for the virus that causes the flu, two wrongs can sometimes make a right.
Posted: June 15, 2017, 9:49 am
The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference highlight the use of two new tools, which can potentially play a pivotal role in the early diagnosis of Systemic Sclerosis.
Posted: June 14, 2017, 3:17 pm
In autoimmune diseases, the immune system wrongly identifies its "enemy", and produces antibodies that attack the patient's own cells.
Posted: June 14, 2017, 9:58 am
Before Ebola virus ever struck West Africa, locals were already on the lookout for a deadly pathogen: Lassa virus.
Posted: June 14, 2017, 2:59 am
For many patients, participating in gene therapy clinical trials isn't an option because their immune system recognizes and fights the helpful virus used for treatment.
Posted: June 14, 2017, 2:34 am
A study by chemists at the University of Connecticut (UConn) offers new evidence that e-cigarettes loaded with a nicotine-based liquid are potentially as harmful as unfiltered cigarettes when it comes to causing DNA damage.
Posted: June 13, 2017, 1:48 pm
UCLA-led researchers have found that Zika viral load and the degree of Zika symptoms during pregnancy were not necessarily associated with problems during pregnancy or fetal abnormalities at birth.
Posted: June 13, 2017, 11:02 am
According to a study carried out at the University of Helsinki, a common periodontal pathogen may delay conception in young women.
Posted: June 13, 2017, 5:23 am